| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2026 | 10 Feb 2026 |
| Inter alia, to consider the following matters :- 1) To consider appointment of Mr Mallour Rajesh Kumar as Additional Director of the Company. 2) To consider appointment of BHAMIDIPATI SURYAPRAKASH (DIN: 03030632) as Independent Directors of the Company. 3) To consider resignation of Ms. Lakshmi Sudha Madala as CFO of the Company. 4) To consider appointment of Company Secretary, Compliance Officer and CFO of the Company. 5) To receive unsecured loans from the Directors or Promoters of the Company or by way of Inter-corporate Loans for fulfilling the obligations of the company. 6) To Consider Shifting of Registered office with in the local limits of Hyderabad. 7) Any other matter with the permission of Chair and majority of Board members present in the meeting. Board meeting outcome (As per BSE Announcement dated on: 12.02.2026) | ||
| Board Meeting | 6 Feb 2026 | 16 Jan 2026 |
| Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Board meeting intimation Intimation of Deferment of Board Meeting (As Per BSE Announcement Dated on 31.01.2026) Standalone Unaudited Financial Results For The Quarter Ended December 31, 2025 (As per BSE Announcement dated on: 06.02.2026) | ||
| Board Meeting | 11 Nov 2025 | 3 Nov 2025 |
| Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Board Meeting intimation Unaudited Financial Results For The Quarter And Half Year Ended Ended September 30, 2025 (As Per BSE Announcement Dated on 11.11.2025) | ||
| Board Meeting | 9 Aug 2025 | 30 Jul 2025 |
| Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2025 inter alia to consider and approve AGM Board meeting outcome (As Per BSE Announcement Dated on: 09/08/2025) | ||
| Board Meeting | 26 Jul 2025 | 15 Jul 2025 |
| Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2025 inter alia to consider and approve Board meeting intimation Standalone Unaudited Financial Results For The Quarter Ended June 30, 2025 (As Per BSE Announcement Dated on: 26.07.2025) | ||
| Board Meeting | 12 Apr 2025 | 4 Apr 2025 |
| Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 inter alia to consider and approve Board meeting Intimation Board meeting outcome Results (As per BSE Announcement Dated on 12/04/2025) | ||
| Board Meeting | 15 Mar 2025 | 15 Mar 2025 |
| Board meeting outcome | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
